Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| RESMED INCRMD · Entity 2692 | Director | November 20, 2025 | November 24, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
RESMED INC
Report date November 20, 2025 · Filed November 24, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| ResMed Common StockSEC Table I · non-derivative | Direct | 5,118 |
Reported balance
After 2025-11-20 transaction · row 1
1 source rowRow 1 · 2025-11-20 · Grant · Acquired 1,073 · Balance 5,118 F1: Shares awarded represent Restricted Stock Units. The RSUs vest in full on the earlier of 11/11/2026, or the annual meeting of stockholders in the year following the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares awarded represent Restricted Stock Units. The RSUs vest in full on the earlier of 11/11/2026, or the annual meeting of stockholders in the year following the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 20, 2025 Filed Nov 24, 2025 20:26 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 1,073 | $0.00 | $0.00 |
DisclosureSEC source: 0000943819-25-000178 · form4.xml · nonDerivative · entry 1 Hernandez John · CIK 0001890555 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,118 F1 · kind: Shares awarded represent Restricted Stock Units. The RSUs vest in full on the earlier of 11/11/2026, or the annual meeting of stockholders in the year following the grant date. Read SEC document |
| August 18, 2025 Filed Aug 19, 2025 17:10 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 2,575 | $0.00 Strike: $148.90 | $0.00 |
DisclosureSEC source: 0001127602-25-020653 · form4.xml · derivative · entry 3 Hernandez John · CIK 0001890555 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: ResMed Common Stock · 2,575 shares Expires 2030-11-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Represents the date options become exercisable. Options vest in full (i) on the first Nov. 11 following the grant date or (ii) the first annual shareholders meeting following grant date. Read SEC document |
| August 18, 2025 Filed Aug 19, 2025 17:10 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 2,575 | $287.10 | $739,289.20 |
DisclosureSEC source: 0001127602-25-020653 · form4.xml · nonDerivative · entry 2 Hernandez John · CIK 0001890555 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,045 F1 · price: This transaction was executed in multiple trades at prices ranging from $286.90 - $287.24. The price reported above reflects the weighted average sale price. Read SEC document |
| August 18, 2025 Filed Aug 19, 2025 17:10 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 2,575 | $148.90 | $383,417.50 |
DisclosureSEC source: 0001127602-25-020653 · form4.xml · nonDerivative · entry 1 Hernandez John · CIK 0001890555 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,620 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 20, 2024 Filed Nov 22, 2024 21:21 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 1,083 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-027901 · form4.xml · nonDerivative · entry 1 Hernandez John · CIK 0001890555 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,045 F1 · kind: Shares awarded represent Restricted Stock Units. The RSUs cliff vest on the earlier of 11/11/2025, or the annual shareholder's meeting in the year following the grant date. Read SEC document |
| November 16, 2023 Filed Nov 21, 2023 01:22 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock Options · Derivative | 2,575 | $148.90 Strike: $148.90 | $383,417.50 |
DisclosureSEC source: 0001127602-23-028088 · form4.xml · derivative · entry 2 Hernandez John · CIK 0001890555 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,575 Underlying: ResMed Common Stock · 2,575 shares Expires 2030-11-16 F2 · derivative.exercise_date: Represents date options first became exercisable. Options vest on the earlier of (i) the first November 11 following the Grant Date, or (ii) the date of the first (1st) annual meeting of stockholders of the Company following the Grant Date. Read SEC document |
| November 16, 2023 Filed Nov 21, 2023 01:22 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 884 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-028088 · form4.xml · nonDerivative · entry 1 Hernandez John · CIK 0001890555 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,962 F1 · shares: Shares awarded represent Restricted Stock Units. The RSUs cliff vest on the earlier of 11/11/2024, or the annual shareholder's meeting in the year following the grant date. Read SEC document |
| November 16, 2022 Filed Nov 18, 2022 23:38 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 1,122 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-026085 · form4.xml · nonDerivative · entry 1 Hernandez John · CIK 0001890555 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,078 F1 · kind: Shares awarded are restricted stock units. The RSUs vest on the earlier of November 11, 2023, or the annual shareholders meeting in the year following the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.